发明名称 |
Controlled release hydrocodone formulations |
摘要 |
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material. |
申请公布号 |
US9572804(B2) |
申请公布日期 |
2017.02.21 |
申请号 |
US201615019106 |
申请日期 |
2016.02.09 |
申请人 |
Purdue Pharma L.P. |
发明人 |
Oshlack Benjamin;Huang Hua-Pin;Masselink John K.;Tonelli Alfred |
分类号 |
A61K31/485;A61K9/00;A61K9/20;A61K9/14;A61K31/46;A61K31/194 |
主分类号 |
A61K31/485 |
代理机构 |
Davidson, Davidson and Kappel, LLC |
代理人 |
Davidson, Davidson and Kappel, LLC |
主权项 |
1. A solid oral controlled-release dosage form of hydrocodone, the dosage form comprising a matrix comprising hydrocodone or a pharmaceutically acceptable salt thereof and a cellulose ether, such that the dosage form provides a ratio of a plasma concentration of hydrocodone at the end of a dosing interval to a maximum plasma concentration of hydrocodone during the dosing interval of from 0.55 to 1 and effective pain relief over a period of time of about 12 hours or longer after administration to a human patient, wherein
the dosage form is a tablet, and the hydrocodone or pharmaceutically acceptable salt thereof is the only active agent in the dosage form. |
地址 |
Stamford CT US |